Prostate cancer survivors' beliefs about screening and treatment decision-making experiences in an era of controversy.

ABSTRACT:

Objective

Controversy about the costs and benefits of screening and treatment of prostate cancer (PCa) has recently intensified. However, the impact of the debate on PCa patients has not been systematically studied.

Methods

We assessed knowledge of, and attitudes toward, the U.S. Preventive Services Task Force's (USPSTF) May 2012 recommendation against PSA-based screening among men diagnosed with clinically localized PCa, and tested whether exposure to the recommendation and associated controversy about overtreatment of PCa predicted treatment decisional conflict, affected treatment choice, or increased regret about PSA testing.

Results

Accurate knowledge of the USPSTF recommendation was uncommon (19.1%). Attitudes toward the recommendation were negative, and the vast

SUBMITTER: Orom H 

PROVIDER: S-EPMC5514549 | biostudies-literature | 2015 Sep

REPOSITORIES: biostudies-literature